OpenURL Connection Search

Select item for more details and to access through your institution.

Bortezomib-containing regimens (BCR) for the treatment of non-transplant eligible multiple myeloma.
Published in:
2017
By:
- Jimenez-Zepeda, Victor;
- Duggan, Peter;
- Neri, Paola;
- Tay, Jason;
- Bahlis, Nizar;
- Jimenez-Zepeda, Victor H;
- Bahlis, Nizar J
Publication type:
journal article
Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results.
Published in:
Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 2, p. 619, doi. 10.1007/s00432-020-03365-w
By:
- Usmani, Saad Z.;
- Mateos, Maria-Victoria;
- Hungria, Vania;
- Iida, Shinsuke;
- Bahlis, Nizar J.;
- Nahi, Hareth;
- Magen, Hila;
- Cavo, Michele;
- Hulin, Cyrille;
- White, Darrell;
- De Stefano, Valerio;
- Fastenau, John;
- Slavcev, Mary;
- Heuck, Christoph;
- Qin, Xiang;
- Pei, Huiling;
- Masterson, Tara;
- Lantz, Kristen;
- Gries, Katharine S.
Publication type:
Article
Impact of COVID-19 on outcomes with teclistamab in patients with relapsed/refractory multiple myeloma in the phase 1/2 MajesTEC-1 study.
Published in:
Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01160-1
By:
- van de Donk, Niels W. C. J.;
- Bahlis, Nizar;
- Costa, Luciano J.;
- Mateos, María-Victoria;
- Nooka, Ajay K.;
- Perrot, Aurore;
- Garfall, Alfred L.;
- Thaman, Pragya;
- Qi, Keqin;
- Uhlar, Clarissa;
- Chastain, Katherine;
- Doyle, Margaret;
- Usmani, Saad Z.
Publication type:
Article
Correction: GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review.
Published in:
2024
By:
- Rodriguez-Otero, Paula;
- van de Donk, Niels W. C. J.;
- Pillarisetti, Kodandaram;
- Cornax, Ingrid;
- Vishwamitra, Deeksha;
- Gray, Kathleen;
- Hilder, Brandi;
- Tolbert, Jaszianne;
- Renaud, Thomas;
- Masterson, Tara;
- Heuck, Christoph;
- Kane, Colleen;
- Verona, Raluca;
- Moreau, Philippe;
- Bahlis, Nizar;
- Chari, Ajai
Publication type:
Correction Notice
GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review.
Published in:
Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-023-00966-9
By:
- Rodriguez-Otero, Paula;
- van de Donk, Niels W. C. J.;
- Pillarisetti, Kodandaram;
- Cornax, Ingrid;
- Vishwamitra, Deeksha;
- Gray, Kathleen;
- Hilder, Brandi;
- Tolbert, Jaszianne;
- Renaud, Thomas;
- Masterson, Tara;
- Heuck, Christoph;
- Kane, Colleen;
- Verona, Raluca;
- Moreau, Philippe;
- Bahlis, Nizar;
- Chari, Ajai
Publication type:
Article
GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review.
Published in:
Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-023-00966-9
By:
- Rodriguez-Otero, Paula;
- van de Donk, Niels W. C. J.;
- Pillarisetti, Kodandaram;
- Cornax, Ingrid;
- Vishwamitra, Deeksha;
- Gray, Kathleen;
- Hilder, Brandi;
- Tolbert, Jaszianne;
- Renaud, Thomas;
- Masterson, Tara;
- Heuck, Christoph;
- Kane, Colleen;
- Verona, Raluca;
- Moreau, Philippe;
- Bahlis, Nizar;
- Chari, Ajai
Publication type:
Article
Impact of elranatamab on quality of life: Patient‐reported outcomes from MagnetisMM‐3.
Published in:
British Journal of Haematology, 2024, v. 204, n. 5, p. 1801, doi. 10.1111/bjh.19346
By:
- Mohty, Mohamad;
- Bahlis, Nizar J.;
- Nooka, Ajay K.;
- DiBonaventura, Marco;
- Ren, Jinma;
- Conte, Umberto
Publication type:
Article
Health‐related quality of life in patients with relapsed or refractory multiple myeloma: treatment with daratumumab, lenalidomide, and dexamethasone in the phase 3 POLLUX trial.
Published in:
British Journal of Haematology, 2021, v. 194, n. 1, p. 132, doi. 10.1111/bjh.17435
By:
- Plesner, Torben;
- Dimopoulos, Meletios A.;
- Oriol, Albert;
- San‐Miguel, Jesus;
- Bahlis, Nizar J.;
- Rabin, Neil;
- Suzuki, Kenshi;
- Yoon, Sung‐Soo;
- Ben‐Yehuda, Dina;
- Cook, Gordon;
- Goldschmidt, Hartmut;
- Grosicki, Sebastian;
- Qin, Xiang;
- Fastenau, John;
- Garvin, Wendy;
- Carson, Robin;
- Renaud, Thomas;
- Gries, Katharine S.
Publication type:
Article
Anti‐myeloma potential of ruxolitinib in co‐existing JAK2V617F‐positive smouldering myeloma and polycythaemia vera.
Published in:
British Journal of Haematology, 2020, v. 189, n. 3, p. e114, doi. 10.1111/bjh.16533
By:
- Lee, Holly;
- McCulloch, Sylvia;
- Mahe, Etienne;
- Shafey, Mona;
- Rashid‐Kolvear, Fariborz;
- Khan, Faisal;
- Prajapati, Dwip;
- Neri, Paola;
- Duggan, Peter;
- Tay, Jason;
- Bahlis, Nizar;
- Jimenez‐Zepeda, Victor H
Publication type:
Article
Pomalidomide plus low‐dose dexamethasone in relapsed refractory multiple myeloma after lenalidomide treatment failure.
Published in:
British Journal of Haematology, 2020, v. 188, n. 4, p. 501, doi. 10.1111/bjh.16213
By:
- Siegel, David S.;
- Schiller, Gary J.;
- Song, Kevin W.;
- Agajanian, Richy;
- Stockerl‐Goldstein, Keith;
- Kaya, Hakan;
- Sebag, Michael;
- Samaras, Christy;
- Malek, Ehsan;
- Talamo, Giampaolo;
- Seet, Christopher S.;
- Mouro, Jorge;
- Pierceall, William E.;
- Zafar, Faiza;
- Chung, Weiyuan;
- Srinivasan, Shankar;
- Agarwal, Amit;
- Bahlis, Nizar J.
Publication type:
Article
Thalidomide-prednisone maintenance following autologous stem cell transplant for Multiple Myeloma: effect on thrombin generation and procoagulant markers in NCIC CTG MY.10.
Published in:
British Journal of Haematology, 2015, v. 168, n. 4, p. 511, doi. 10.1111/bjh.13176
By:
- Kovacs, Michael J.;
- Davies, Gwynivere A.;
- Chapman, Judy‐Anne W.;
- Bahlis, Nizar;
- Voralia, Michael;
- Roy, Jean;
- Kouroukis, C. Tom;
- Chen, Christine;
- Belch, Andrew;
- Reece, Donna;
- Zhu, Liting;
- Meyer, Ralph M.;
- Shepherd, Lois;
- Stewart, Keith A.
Publication type:
Article
Amyloidosis and COVID-19: experience from an amyloid program in Canada.
Published in:
Annals of Hematology, 2022, v. 101, n. 10, p. 2307, doi. 10.1007/s00277-022-04964-y
By:
- Lewis, Ellen;
- Fine, Nowell;
- Miller, Robert J. H.;
- Hahn, Christopher;
- Chhibber, Sameer;
- Mahe, Etienne;
- Tay, Jason;
- Duggan, Peter;
- McCulloch, Sylvia;
- Bahlis, Nizar;
- Neri, Paola;
- Jimenez-Zepeda, Victor H.
Publication type:
Article
N-Terminal pro-brain natriuretic peptide (NTproBNP) in patients with symptomatic multiple myeloma: report from a single institution.
Published in:
Annals of Hematology, 2021, v. 100, n. 10, p. 2521, doi. 10.1007/s00277-021-04591-z
By:
- Jimenez-Zepeda, Victor H.;
- Lee, Holly;
- Tay, Jason;
- Duggan, Peter;
- McCulloch, Sylvia;
- Neri, Paola;
- Bahlis, Nizar J.
Publication type:
Article
Subcutaneous daratumumab in Asian patients with heavily pretreated multiple myeloma: subgroup analyses of the noninferiority, phase 3 COLUMBA study.
Published in:
Annals of Hematology, 2021, v. 100, n. 4, p. 1065, doi. 10.1007/s00277-021-04405-2
By:
- Iida, Shinsuke;
- Ishikawa, Takayuki;
- Min, Chang Ki;
- Kim, Kihyun;
- Yeh, Su Peng;
- Usmani, Saad Z.;
- Mateos, Maria-Victoria;
- Nahi, Hareth;
- Heuck, Christoph;
- Qin, Xiang;
- Parasrampuria, Dolly A.;
- Gries, Katharine S.;
- Qi, Ming;
- Bahlis, Nizar;
- Ito, Shigeki
Publication type:
Article
Differentiation of acute and chronic myeloid leukemic blasts into the dendritic cell lineage: analysis of various differentiation-inducing signals.
Published in:
Cancer Immunology, Immunotherapy, 2005, v. 54, n. 1, p. 25, doi. 10.1007/s00262-004-0562-4
By:
- Kharfan-Dabaja, Mohamed;
- Ayala, Ernesto;
- Lindner, Inna;
- Cejas, Pedro;
- Bahlis, Nizar;
- Kolonias, Despina;
- Carlson, Louise;
- Lee, Kelvin
Publication type:
Article
Multiple myeloma immunoglobulin lambda translocations portend poor prognosis.
Published in:
Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-09555-6
By:
- Barwick, Benjamin G.;
- Neri, Paola;
- Bahlis, Nizar J.;
- Nooka, Ajay K.;
- Dhodapkar, Madhav V.;
- Jaye, David L.;
- Hofmeister, Craig C.;
- Kaufman, Jonathan L.;
- Gupta, Vikas A.;
- Auclair, Daniel;
- Keats, Jonathan J.;
- Lonial, Sagar;
- Vertino, Paula M.;
- Boise, Lawrence H.
Publication type:
Article
The impact of COVID‐19 in the management of AL amyloidosis and Immunoglobulin Deposition Disease: A single‐center experience.
Published in:
European Journal of Haematology, 2021, v. 106, n. 3, p. 340, doi. 10.1111/ejh.13552
By:
- Lee, Holly;
- Tay, Jason;
- Duggan, Peter;
- McCulloch, Sylvia;
- Neri, Paola;
- Bahlis, Nizar J.;
- Jimenez‐Zepeda, Victor H.
Publication type:
Article
Clinical benefit of ixazomib plus lenalidomide‐dexamethasone in myeloma patients with non‐canonical NF‐κB pathway activation.
Published in:
European Journal of Haematology, 2020, v. 105, n. 3, p. 274, doi. 10.1111/ejh.13435
By:
- Dash, Ajeeta B.;
- Zhang, Jacob;
- Shen, Lei;
- Li, Bin;
- Berg, Deborah;
- Lin, Jianchang;
- Avet‐Loiseau, Hervé;
- Bahlis, Nizar J.;
- Moreau, Philippe;
- Richardson, Paul G.;
- Di Bacco, Alessandra
Publication type:
Article
c‐MYC expression and maturity phenotypes are associated with outcome benefit from addition of ixazomib to lenalidomide‐dexamethasone in myeloma.
Published in:
European Journal of Haematology, 2020, v. 105, n. 1, p. 35, doi. 10.1111/ejh.13405
By:
- Di Bacco, Alessandra;
- Bahlis, Nizar J.;
- Munshi, Nikhil C.;
- Avet‐Loiseau, Hervé;
- Masszi, Tamás;
- Viterbo, Luísa;
- Pour, Ludek;
- Ganly, Peter;
- Cavo, Michele;
- Langer, Christian;
- Kumar, Shaji K.;
- Rajkumar, S. Vincent;
- Keats, Jonathan J.;
- Berg, Deborah;
- Lin, Jianchang;
- Li, Bin;
- Badola, Sunita;
- Shen, Lei;
- Zhang, Jacob;
- Esseltine, Dixie‐Lee
Publication type:
Article
Continuous lenalidomide and low‐dose dexamethasone in patients with transplant‐ineligible newly diagnosed MM: FIRST trial subanalysis of Canadian/US patients.
Published in:
Cancer Medicine, 2020, v. 9, n. 23, p. 8923, doi. 10.1002/cam4.3511
By:
- Belch, Andrew;
- Bahlis, Nizar;
- White, Darrell;
- Cheung, Matthew;
- Chen, Christine;
- Shustik, Chaim;
- Song, Kevin;
- Tosikyan, Axel;
- Dispenzieri, Angela;
- Anderson, Kenneth;
- Brown, Diane;
- Robinson, Suzanne;
- Srinivasan, Shankar;
- Facon, Thierry
Publication type:
Article
Lenalidomide Plus Melphalan Without Prednisone for Previously Untreated Older Patients With Multiple Myeloma: A Phase II Trial.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 1, p. 19, doi. 10.1016/j.clml.2012.08.009
By:
- White, Darrell J.;
- Bahlis, Nizar J.;
- Marcellus, Deb C.;
- Belch, Andrew;
- Keith Stewart, A.;
- Chen, Christine;
- Kovacs, Michael J.;
- Macdonald, David A.;
- Reece, Donna E.;
- Reiman, Tony;
- Harnett, Erica;
- Meyer, Ralph M.;
- Chapman, Judy-Anne W.;
- Couban, Stephen
Publication type:
Article
An Open-Label Single-Arm Pilot Phase II Study (PX-171-003-A0) of Low-Dose, Single-Agent Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2012, v. 12, n. 5, p. 310, doi. 10.1016/j.clml.2012.08.003
By:
- Jagannath, Sundar;
- Vij, Ravi;
- Stewart, A. Keith;
- Trudel, Suzanne;
- Jakubowiak, Andrzej J.;
- Reiman, Tony;
- Somlo, George;
- Bahlis, Nizar;
- Lonial, Sagar;
- Kunkel, Lori A.;
- Wong, Alvin;
- Orlowski, Robert Z.;
- Siegel, David S.
Publication type:
Article
A Prospective Phase II Study of RICE Re-Induction, Then High-Dose Fludarabine and Busulfan, Followed by Autologous or Allogeneic Blood Stem Cell Transplantation for Indolent B-Cell Lymphoma. ClinicalTrials.gov ID: NCT00144092.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 6, p. 475, doi. 10.1016/j.clml.2011.06.012
By:
- Stewart, Douglas A.;
- Duan, Qiuli;
- Carlson, Linda;
- Russell, James A.;
- Bahlis, Nizar J.;
- Duggan, Peter;
- Hasegawa, Wanda;
- Voralia, Michael
Publication type:
Article
Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone: A pooled analysis.
Published in:
European Journal of Haematology, 2017, v. 99, n. 3, p. 199, doi. 10.1111/ejh.12903
By:
- Moreau, Philippe;
- Dimopoulos, Meletios A.;
- Richardson, Paul G.;
- Siegel, David S.;
- Cavo, Michele;
- Corradini, Paolo;
- Weisel, Katja;
- Delforge, Michel;
- O'Gorman, Peter;
- Song, Kevin;
- Chen, Christine;
- Bahlis, Nizar;
- Oriol, Albert;
- Hansson, Markus;
- Kaiser, Martin;
- Anttila, Pekka;
- Raymakers, Reinier;
- Joao, Cristina;
- Cook, Gordon;
- Sternas, Lars
Publication type:
Article
Alkaline phosphatase variation during carfilzomib treatment is associated with best response in multiple myeloma patients.
Published in:
European Journal of Haematology, 2011, v. 86, n. 6, p. 484, doi. 10.1111/j.1600-0609.2011.01602.x
By:
- Zangari, Maurizio;
- Aujay, Monette;
- Fenghuang Zhan;
- Hetherington, Kristina L.;
- Berno, Tamara;
- Vij, Ravi;
- Jagannath, Sundar;
- Siegel, David;
- Stewart, A. Keith;
- Wang, Luhua;
- Orlowski, Robert Z.;
- Belch, Andrew;
- Jakubowiak, Andrzej;
- Somlo, George;
- Trudel, Suzanne;
- Bahlis, Nizar;
- Lonial, Sagar;
- Singhal, Seema;
- Kukreti, Vishal;
- Tricot, Guido
Publication type:
Article
CNV Radar: an improved method for somatic copy number alteration characterization in oncology.
Published in:
BMC Bioinformatics, 2020, v. 21, n. 1, p. 1, doi. 10.1186/s12859-020-3397-x
By:
- Soong, David;
- Stratford, Jeran;
- Avet-Loiseau, Herve;
- Bahlis, Nizar;
- Davies, Faith;
- Dispenzieri, Angela;
- Sasser, A. Kate;
- Schecter, Jordan M.;
- Qi, Ming;
- Brown, Chad;
- Jones, Wendell;
- Keats, Jonathan J.;
- Auclair, Daniel;
- Chiu, Christopher;
- Powers, Jason;
- Schaffer, Michael
Publication type:
Article
Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma: Results From the Phase II MajesTEC-1 Study.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 3, p. 194, doi. 10.1016/j.clml.2023.11.001
By:
- Martin, Thomas G.;
- Moreau, Philippe;
- Usmani, Saad Z.;
- Garfall, Alfred;
- Mateos, Maria-Victoria;
- San-Miguel, Jesus F.;
- Oriol, Albert;
- Nooka, Ajay K.;
- Rosinol, Laura;
- Chari, Ajai;
- Karlin, Lionel;
- Krishnan, Amrita;
- Bahlis, Nizar;
- Popat, Rakesh;
- Besemer, Britta;
- Martfnez-Lopez, Joaquin;
- Delforge, Michel;
- Trancucci, Danielle;
- Pei, Lixia;
- Kobos, Rachel
Publication type:
Article
Effect of the Presence of t(11;14) for Patients With AL Amyloidosis Treated With Bortezomib-Containing Regimens: Experience From the Amyloidosis Program of Calgary.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. e331, doi. 10.1016/j.clml.2023.07.004
By:
- Lewis, Ellen;
- McCulloch, Sylvia;
- Mahe, Etienne;
- Bahlis, Nizar;
- Neri, Paola;
- Tay, Jason;
- Duggan, Peter;
- Jimenez-Zepeda, Victor H.
Publication type:
Article
Selinexor-Based Triplet Regimens in Patients With Multiple Myeloma Previously Treated With Anti-CD38 Monoclonal Antibodies.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 9, p. e286, doi. 10.1016/j.clml.2023.06.001
By:
- Schiller, Gary J.;
- Lipe, Brea C.;
- Bahlis, Nizar J.;
- Tuchman, Sascha A.;
- Bensinger, William I.;
- Sutherland, Heather J.;
- Lentzsch, Suzanne;
- Baljevic, Muhamed;
- White, Darrell;
- Kotb, Rami;
- Chen, Christine I.;
- Rossi, Adriana;
- Biran, Noa;
- LeBlanc, Richard;
- Grosicki, Sebastian;
- Martelli, Maurizio;
- Gunsilius, Eberhard;
- Špicka, Ivan;
- Stevens, Don Ambrose;
- Facon, Thierry
Publication type:
Article
Real-world Outcomes With Cumulative Bortezomib Dose and Efficacy in the Treatment of Transplant-ineligible Multiple Myeloma With Cyclophosphamide, Bortezomib, and Dexamethasone.
Published in:
2023
By:
- Nie, Chunpeng;
- Lee, Holly;
- Tay, Jason;
- Duggan, Peter;
- McCulloch, Sylvia;
- Neri, Paola;
- Bahlis, Nizar J;
- Jimenez-Zepeda, Victor H
Publication type:
journal article
P-189: Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma (MM-014 phase 2 trial): a subanalysis of patients previously treated with lenalidomide and a proteasome inhibitor.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S141, doi. 10.1016/S2152-2650(21)02316-8
By:
- Bahlis, Nizar J.;
- Schiller, Gary J.;
- Sebag, Michael;
- Berdeja, Jesus G.;
- Ganguly, Siddhartha;
- Matous, Jeffrey V.;
- Song, Kevin;
- Seet, Christopher;
- Acosta-Rivera, Mirelis;
- Bar, Michael;
- Quick, Donald;
- Anz, Bertrand M.;
- Fonseca, Gustavo;
- Reece, Donna E.;
- Vogel, Prisca;
- Kim Lee;
- Weiyuan Chung;
- Agarwal, Amit;
- Siegel, David S.
Publication type:
Article
OAB-026: MagnetisMM-1 study of elranatamab (PF-06863135), a B-cell maturation antigen (BCMA) targeted CD3-engaging bispecific molecule, for patients (pts) with relapsed or refractory multiple myeloma (MM).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S17, doi. 10.1016/S2152-2650(21)02100-5
By:
- Dholaria, Bhagirathbhai;
- Bahlis, Nizar;
- Raje, Noopur;
- Costello, Caitlin;
- Solh, Melhem;
- Levy, Moshe;
- Tomasson, Michael;
- Dube, Harman;
- Damore, Michael;
- Hoi Kei Lon;
- Basu, Cynthia;
- Skoura, Athanasia;
- Chan, Edward;
- Trudel, Suzanne;
- Jakubowiak, Andrzej;
- Chu, Michael;
- Gasparetto, Cristina;
- Dalovisio, Andrew;
- Sebag, Michael;
- Lesokhin, Alexander
Publication type:
Article
OAB-018: A BCL2L1 armoured BCMA-targeting CAR T cells to overcome exhaustion and enhance persistence in multiple myeloma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S12, doi. 10.1016/S2152-2650(21)02092-9
By:
- Maity, Ranjan;
- Benaoudia, Sacha;
- Lee, Holly;
- Barakat, Elie;
- Leblay, Noemie;
- Ahn, Sungwoo;
- Zemp, Franz;
- Mahoney, Douglas;
- Neri, Paola;
- Bahlis, Nizar
Publication type:
Article
OAB-001: Overall survival and progression-free survival by treatment duration with Daratumumab + Lenalidomide/Dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: phase 3 MAIA study.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S1, doi. 10.1016/S2152-2650(21)02075-9
By:
- Moreau, Philippe;
- Facon, Thierry;
- Kumar, Shaji;
- Plesner, Torben;
- Orlowski, Robert Z.;
- Bahlis, Nizar;
- Basu, Supratik;
- Nahi, Hareth;
- Hulin, Cyrille;
- Hang Quach;
- Goldschmidt, Hartmut;
- O'Dwyer, Michael;
- Perrot, Aurore;
- Venner, Christopher;
- Weisel, Katja;
- Mace, Joseph R.;
- Raje, Noopur;
- Tiab, Mourad;
- Macro, Margaret;
- Frenzel, Laurent
Publication type:
Article
MM-379: MagnetisMM-1: A Study of Elranatamab (PF-06863135), a B-Cell Maturation Antigen (BCMA)-Targeted, CD3-Engaging Bispecific Antibody, for Patients with Relapsed or Refractory Multiple Myeloma (MM).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S439, doi. 10.1016/S2152-2650(21)01978-9
By:
- Levy, Moshe;
- Bahlis, Nizar;
- Raje, Noopur;
- Costello, Caitlin;
- Dholaria, Bhagirathbhai;
- Solh, Melhem;
- Tomasson, Michael;
- Dube, Harman;
- Damore, Michael;
- Hoi Kei Lon;
- Basu, Cynthia;
- Skoura, Athanasia;
- Chan, Edward;
- Trudel, Suzanne;
- Jakubowiak, Andrzej;
- Chu, Michael;
- Gasparetto, Cristina;
- Dalovisio, Andrew;
- Sebag, Michael;
- Lesokhin, Alexander
Publication type:
Article
MM-155: Phase 3 MAIA Study: Overall Survival (OS) Results with Daratumumab, Lenalidomide, and Dexamethasone (D-Rd) vs Lenalidomide and Dexamethasone (Rd) in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma (TIE-NDMM).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S424, doi. 10.1016/S2152-2650(21)01950-9
By:
- Orlowski, Robert;
- Facon, Thierry;
- Kumar, Shaji;
- Plesner, Torben;
- Moreau, Philippe;
- Bahlis, Nizar;
- Basu, Supratik;
- Nahi, Hareth;
- Hulin, Cyrille;
- Quach, Hang;
- Goldschmidt, Hartmut;
- O'Dwyer, Michael;
- Perrot, Aurore;
- Venner, Christopher;
- Weisel, Katja;
- Mace, Joseph;
- Raje, Noopur;
- Tiab, Mourad;
- Macro, Margaret;
- Frenzel, Laurent
Publication type:
Article
Poster: MM-155: Phase 3 MAIA Study: Overall Survival (OS) Results with Daratumumab, Lenalidomide, and Dexamethasone (D-Rd) vs Lenalidomide and Dexamethasone (Rd) in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma (TIE-NDMM).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S252, doi. 10.1016/S2152-2650(21)01581-0
By:
- Orlowski, Robert;
- Facon, Thierry;
- Kumar, Shaji;
- Plesner, Torben;
- Moreau, Philippe;
- Bahlis, Nizar;
- Basu, Supratik;
- Nahi, Hareth;
- Hulin, Cyrille;
- Quach, Hang;
- Goldschmidt, Hartmut;
- O'Dwyer, Michael;
- Perrot, Aurore;
- Venner, Christopher;
- Weisel, Katja;
- Mace, Joseph;
- Raje, Noopur;
- Tiab, Mourad;
- Macro, Margaret;
- Frenzel, Laurent
Publication type:
Article
Poster: MM-379: MagnetisMM-1: A Study of Elranatamab (PF-06863135), a B-Cell Maturation Antigen (BCMA)-Targeted, CD3-Engaging Bispecific Antibody, for Patients with Relapsed or Refractory Multiple Myeloma (MM).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S252, doi. 10.1016/S2152-2650(21)01578-0
By:
- Levy, Moshe;
- Bahlis, Nizar;
- Raje, Noopur;
- Costello, Caitlin;
- Dholaria, Bhagirathbhai;
- Solh, Melhem;
- Tomasson, Michael;
- Dube, Harman;
- Damore, Michael;
- Lon, Hoi Kei;
- Basu, Cynthia;
- Skoura, Athanasia;
- Chan, Edward;
- Trudel, Suzanne;
- Jakubowiak, Andrzej;
- Chu, Michael;
- Gasparetto, Cristina;
- Dalovisio, Andrew;
- Sebag, Michael;
- Lesokhin, Alexander
Publication type:
Article
Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) for the Treatment of Newly Diagnosed AL Amyloidosis: Impact of Response on Survival Outcomes.
Published in:
2020
By:
- Diaz-Pallares, Carolina;
- Lee, Holly;
- Luider, Joanne;
- Duggan, Peter;
- Neri, Paola;
- Tay, Jason;
- MacCulloch, Sylvia;
- Bahlis, Nizar J.;
- Jimenez-Zepeda, Victor H.
Publication type:
journal article
Health-Related Quality of Life With Pomalidomide + Dexamethasone + Daratumumab After Lenalidomide in Relapsed or Refractory Multiple Myeloma Patients.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e277, doi. 10.1016/j.clml.2019.09.457
By:
- Reece, Donna;
- Bahlis, Nizar J.;
- Samaras, Christy Joy;
- Sebag, Michael;
- Berdeja, Jesus;
- Ganguly, Siddhartha;
- Matous, Jeffrey;
- Song, Kevin;
- Seet, Christopher S.;
- Talamo, Giampaolo;
- Acosta-Rivera, Mirelis;
- Bar, Michael;
- Quick, Donald;
- Anz, Bertrand;
- Fonseca, Gustavo;
- Agarwal, Amit;
- Chung, Weiyuan;
- Zafar, Faiza;
- Siegel, David S.
Publication type:
Article
Greater Treatment Satisfaction in Patients Receiving Subcutaneous (SC) Versus Intravenous (IV) Daratumumab (DARA) for Relapsed or Refractory Multiple Myeloma (RRMM): COLUMBA.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e247, doi. 10.1016/j.clml.2019.09.410
By:
- Usmani, Saad;
- Mateos, Maria-Victoria;
- Hungria, Vania;
- Iida, Shinsuke;
- Bahlis, Nizar J.;
- Nahi, Hareth;
- Magen, Hila;
- Cavo, Michele;
- HULIN, Cyrille;
- White, Darrell;
- De Stefano, Valerio;
- Slavcev, Mary;
- Heuck, Christoph;
- Qin, Xiang;
- Masterson, Tara;
- Lantz, Kristen;
- Gries, Katharine
Publication type:
Article
A Randomized Phase 2 Study of Subcutaneous Daratumumab Plus Carfilzomib/Dexamethasone Versus Carfilzomib/Dexamethasone Alone in Patients with Multiple Myeloma who have been Previously Treated with Intravenous Daratumumab to Evaluate Retreatment (LYNX).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e246, doi. 10.1016/j.clml.2019.09.408
By:
- Bahlis, Nizar J.;
- Zonder, Jeffrey A.;
- Wroblewski, Susan;
- Qi, Ming;
- Renaud, Thomas;
- Jackson, Carolyn;
- Facon, Thierry
Publication type:
Article
Daratumumab, Lenalidomide, and Dexamethasone (D-Rd) Delivers a Reduction and Delay in Worsening of Pain Symptoms for Patients with Newly Diagnosed Multiple Myeloma Ineligible for Transplant.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e225, doi. 10.1016/j.clml.2019.09.375
By:
- Gries, Katharine;
- Facon, Thierry;
- Plesner, Torben;
- Usmani, Saad;
- Kumar, Shaji;
- Orlowski, Robert Z.;
- Bahlis, Nizar J.;
- Nahi, Hareth;
- Mollee, Peter;
- Ramasamy, Karthik;
- ROUSSEL, Murielle;
- Delforge, Michel;
- KARLIN, Lionel;
- Arnulf, Bertrand;
- Chari, Ajai;
- HULIN, Cyrille;
- Weisel, Katja;
- He, Jianming;
- Ho, Kai Fai;
- Wang, Jim
Publication type:
Article
Phase 3 FIRST Trial in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Subgroup Analysis of Patients From Canada and the United States.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e225, doi. 10.1016/j.clml.2019.09.374
By:
- Belch, Andrew;
- Bahlis, Nizar J.;
- White, Darrell;
- Cheung, Matthew;
- Chen, Christine;
- Shustik, Chaim;
- Song, Kevin;
- Tosikyan, Axel;
- Dispenzieri, Angela;
- Anderson, Kenneth C.;
- Kotey, Stanley;
- Brown, Diane;
- Robinson, Suzanne;
- Srinivasan, Shankar;
- Facon, Thierry
Publication type:
Article
Mass cytometry reveals increase in marrow resident monocytes associated with response to daratumumab and pomalidomide.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e99, doi. 10.1016/j.clml.2019.09.162
By:
- Van Oekelen, Oliver;
- Rahman, Adeeb;
- Lagana, Alessandro;
- Young, Mary;
- Pierceall, William;
- Thakurta, Anjan;
- Neri, Paola;
- Bahlis, Nizar J.;
- Parekh, Samir
Publication type:
Article
Safety and Efficacy of the Combination of Selinexor, Lenalidomide and Dexamethasone (SRd) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e55, doi. 10.1016/j.clml.2019.09.084
By:
- White, Darrell;
- LeBlanc, Richard;
- Venner, Chritopher;
- Bahlis, Nizar J.;
- Lentzsch, Suzanne;
- Gasparetto, Cristina J.;
- Chen, Christine;
- Lipe, Brea;
- Sutherland, Heather;
- Tuchman, Sascha;
- Baljevic, Muhamed;
- Kotb, Rami;
- Sebag, Michael;
- Callander, Nancy;
- Bensinger, William;
- Kai, Kazuharu;
- Liu, Jianjun;
- Sheehan, Heidi;
- Estepan, Daniel Nova;
- Shah, Jatin
Publication type:
Article
A Phase 1, First-in-Human Study of AMG 176, a Selective MCL-1 Inhibitor, in Patients With Relapsed or Refractory Multiple Myeloma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e53, doi. 10.1016/j.clml.2019.09.081
By:
- Spencer, Andrew;
- Rosenberg, Aaron Seth;
- Jakubowiak, Andrzej;
- Raje, Noopur;
- Chatterjee, Manik;
- Trudel, Suzanne;
- Bahlis, Nizar J.;
- Siegel, David S.;
- Wilop, Stefan;
- Harrison, Simon J.;
- NagaKrishna, Murthy;
- Dhuria, Shyeilla;
- Hindoyan, Antreas;
- McIver, Zach;
- Henary, Haby;
- Morrow, Phuong Khanh;
- Roberts, Andrew
Publication type:
Article
Expansion of effector memory CD27+ T cells and tolerogenic type 2 classical dendritic cells regulate myeloma patients' sensitivity to daratumumab & IMiDs.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e29, doi. 10.1016/j.clml.2019.09.044
By:
- Neri, Paola;
- Alberge, Jean-Baptiste;
- Maity, Ranjan;
- McCulloch, Sylvia;
- Tay, Jason;
- Jimenez-Zepeda, Victor;
- Minivielle, Stephane;
- Bahlis, Nizar J.
Publication type:
Article
Copy number gain of the MCL1 gene locus (1q21) and acquisition of BCL2 mutation mediate resistance to venetoclax in multiple myeloma (MM) patients.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e22, doi. 10.1016/j.clml.2019.09.033
By:
- Maity, Ranjan;
- Neri, Paola;
- Donovan, Justin;
- Kong, Madison;
- Hasan, Fajer;
- Boise, Lawrence;
- Bahlis, Nizar J.
Publication type:
Article
Early Relapse for Multiple Myeloma Patients Undergoing Single Autologous Stem Cell Therapy: A Single-center Experience.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, n. 1, p. e69, doi. 10.1016/j.clml.2017.10.009
By:
- Lee, Holly;
- Duggan, Peter;
- Chaudhry, Ahsan;
- Neri, Paola;
- Tay, Jason;
- Rashid-Kolvear, Fariborz;
- Bahlis, Nizar J.;
- Jimenez-Zepeda, Victor H.
Publication type:
Article

Found: 80